Last reviewed · How we verify

NCT07155577

Effects of Pes Planus on Gait at Different Inclines

Recruiting now Last updated 9 January 2026
What this trial tests

trial in Flatfoot in 30 participants. Currently enrolling.

Timeline
1 July 2025
Primary endpoint
25 January 2026
1 May 2026

Quick facts

Lead sponsorHacettepe University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment30
Start date1 July 2025
Primary completion25 January 2026
Estimated completion1 May 2026
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 18 to 35, any sex, with Flatfoot or Gait. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the effects of pes planus deformity on gait spatiotemporal parameters and pelvic kinematics during walking on different inclines. Participants will include healthy adults aged 18-35 years with flexible bilateral pes planus and normal body mass index. Pes planus severity will be evaluated using the Jack's toe-raise test and the navicular drop test. Gait parameters such as walking speed, cadence, stride length, stance and swing phase percentages, gait cycle duration, as well as pelvic tilt, obliquity, and rotation symmetry will be measured using the BTS-G wireless sensor system. Assessments will be performed on both flat and inclined treadmill conditions. The findings are expected to provide new insights into the biomechanical adaptations of pes planus during walking and contribute to the development of an individualized rehabilitation protocol.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Flatfoot

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07155577.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing